Avid Bioservices, Inc. (CDMO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Avid Bioservices, Inc. (CDMO)
Company Performance

Current Price

as of Oct 16, 2024

$10.20

P/E Ratio

N/A

Market Cap

$650.71M

Description

Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Metrics

Overview

  • HQTustin, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerCDMO
  • Price$10.2-0.68%

Trading Information

  • Market Cap$650.71M
  • Float98.56%
  • Average Daily Volume (1m)899,551
  • Average Daily Volume (3m)890,443
  • EPS-$2.27

Company

  • Revenue$142.36M
  • Rev Growth (1yr)6.49%
  • Net Income-$5.53M
  • Gross Margin14.22%
  • EBITDA Margin1.17%
  • EBITDA$0.47M
  • EV$835.04M
  • EV/Revenue5.87
  • P/EN/A
  • P/S4.56
  • P/B11.10